Drug resistance is a significant challenge in cancer treatment. Cancer cells can develop resistance through various mechanisms, such as drug efflux, mutation of drug targets, or activation of alternative pathways. Overcoming drug resistance often requires combination therapies, novel drug designs, or personalized medicine approaches based on genetic profiling of the tumor.
